21-hydroxylase deficiency differential diagnosis: Difference between revisions
No edit summary |
|||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Congenital adrenal hyperplasia]] due to 21-hydroxylase deficiency must be differentiated from | [[Congenital adrenal hyperplasia]] due to 21-hydroxylase deficiency must be differentiated from [[Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency|11-β hydroxylase deficiency]], [[Congenital adrenal hyperplasia due to 17 alpha-hydroxylase deficiency|17-α hydroxylase deficiency]], [[androgen insensitivity syndrome]], [[polycystic Ovarian Syndrome]], and [[adrenal tumor]]. | ||
==Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases== | ==Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases== | ||
[[Congenital adrenal hyperplasia]] due to 21-hydroxylase deficiency must be differentiated from | [[Congenital adrenal hyperplasia]] due to 21-hydroxylase deficiency must be differentiated from: | ||
*[[Androgen insensitivity syndrome]] | *[[Androgen insensitivity syndrome]] | ||
*11-β hydroxylase deficiency | *11-β hydroxylase deficiency |
Revision as of 14:27, 5 October 2015
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency Microchapters |
Differentiating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
21-hydroxylase deficiency differential diagnosis On the Web |
American Roentgen Ray Society Images of 21-hydroxylase deficiency differential diagnosis |
21-hydroxylase deficiency differential diagnosis in the news |
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 21-hydroxylase deficiency |
Risk calculators and risk factors for 21-hydroxylase deficiency differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency must be differentiated from 11-β hydroxylase deficiency, 17-α hydroxylase deficiency, androgen insensitivity syndrome, polycystic Ovarian Syndrome, and adrenal tumor.
Differentiating congenital adrenal hyperplasia due to 21-hydroxylase deficiency from other diseases
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency must be differentiated from:
- Androgen insensitivity syndrome
- 11-β hydroxylase deficiency
- 17-α hydroxylase deficiency
- Polycystic Ovarian Syndrome
- Adrenal tumor